Literature DB >> 11328342

An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors.

V Bruno1, G Battaglia, A Copani, V M Cespédes, M F Galindo, V Ceña, J Sánchez-Prieto, F Gasparini, R Kuhn, P J Flor, F Nicoletti.   

Abstract

Activation of group I metabotropic glutamate receptors (mGlu1 or -5 receptors) is known to either enhance or attenuate excitotoxic neuronal death depending on the experimental conditions. We have examined the possibility that these receptors may switch between two different functional modes in regulating excitotoxicity. In mixed cultures of cortical cells, the selective mGlu1/5 agonist, 3,5-dihydroxyphenylglycine (DHPG), amplified neurodegeneration induced by a toxic pulse of NMDA. This effect was observed when DHPG was either combined with NMDA or transiently applied to the cultures prior to the NMDA pulse. However, two consecutive applications of DHPG consistently produced neuroprotection. Similar effects were observed with DHPG or quisqualate (a potent agonist of mGlu1/5 receptors) in pure cultures of cortical neurons virtually devoid of astrocytes. In cultures of hippocampal pyramidal neurons, however, only protective effects of DHPG were seen suggesting that, in these particular cultures, group I mGlu receptors were endogenously switched into a "neuroprotective mode". The characteristics of the activity-dependent switch from facilitation to inhibition were examined in mixed cultures of cortical cells. The switch in the response to DHPG was observed when the two applications of the drug were separated by an interval ranging from 1-45 min, but was lost when the interval was extended to 90 min. In addition, this phenomenon required the initial activation of mGlu5 receptors (as indicated by the use of subtype-selective antagonists) and was mediated by the activation of protein kinase C. We conclude that group I mGlu receptors are subjected to an activity-dependent switch in regulating excitotoxic neuronal death and, therefore, the recent "history" of these receptors is critical for the response to agonists or antagonists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328342     DOI: 10.1046/j.0953-816x.2001.01541.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  19 in total

Review 1.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

Review 2.  Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function.

Authors:  Ana Sanchez-Perez; Marta Llansola; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 3.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

Review 4.  Huntington's disease and Group I metabotropic glutamate receptors.

Authors:  Fabiola M Ribeiro; Rita G W Pires; Stephen S G Ferguson
Journal:  Mol Neurobiol       Date:  2010-12-09       Impact factor: 5.590

5.  Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.

Authors:  Benjamin Ray Miller; Ilya Bezprozvanny
Journal:  Future Neurol       Date:  2010-09

6.  Glutamate differently modulates metabotropic glutamate receptors in neuronal and glial cells.

Authors:  Carlos Alberto Castillo; David Agustín León; Inmaculada Ballesteros-Yáñez; Inmaculada Iglesias; Mairena Martín; José Luis Albasanz
Journal:  Neurochem Res       Date:  2010-03-23       Impact factor: 3.996

7.  Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.

Authors:  Yi-Min Kuo; Pei-Chien Hsu; Chia-Chi Hung; Ya-Yu Hu; Yu-Jie Huang; Yu-Ling Gan; Chun-Hua Lin; Feng-Shiun Shie; Wen-Kuei Chang; Lung-Sen Kao; Mei-Yung Tsou; Yi-Hsuan Lee
Journal:  Mol Neurobiol       Date:  2019-07-01       Impact factor: 5.590

8.  Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells.

Authors:  I Sarnico; F Boroni; M Benarese; S Sigala; A Lanzillotta; L Battistin; P Spano; M Pizzi
Journal:  J Neural Transm (Vienna)       Date:  2007-12-19       Impact factor: 3.575

9.  Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1alpha in early chemical hypoxia-mediated neurotoxicity.

Authors:  Inmaculada Posadas; Beatriz López-Hernández; Maria Isabel Clemente; Jose Luis Jiménez; Paula Ortega; Javier de la Mata; Rafael Gómez; María Angeles Muñoz-Fernández; Valentín Ceña
Journal:  Pharm Res       Date:  2009-02-04       Impact factor: 4.200

10.  Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.

Authors:  J G Doria; F R Silva; J M de Souza; L B Vieira; T G Carvalho; H J Reis; G S Pereira; T Dobransky; F M Ribeiro
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.